Selected Publications

Laczko D, Poveda-Rogers C, Matthews AH, Snaith O, Luger S, Bagg A, Caponetti GC, Morrissette JJD, Yang G.: RAD21 mutations in acute myeloid leukemia. Leuk & Lymphoma Mar 2024.

Matthews A, Fenu E, Skuli SJ, Harris JC, Lai C.: Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach. Leuk & Lymphoma Mar 2024.

Matthews A, Fenu E, Skuli SJ, Harris JC, Lai C.: Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach. Leuk & Lymphoma Mar 2024.

Abaza Y, Winer ES, Murthy GSG, Shallis RM, Matthews AH, Badar T, Geramita EM, Kota VK, Swaroop A, Doukas P, Bradshaw D, Helenowski IB, Liu Y, Zhang H, Im A, Litzow MR, Perl AE, Atallah E, Altman JK.: Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers. Am J Hematol 99(4), Feb 2024.

Matthews AH, Perl AE, Luger SM, Loren AW, Gill SI, Porter DL, Babushok DV, Maillard I, Carroll MP, Frey NV, Hexner E, Martin ME, McCurdy SR, Stadtmauer EA, Paralkar VR, Jordan Bruno X, Hwang WT, Margolis D, Pratz KW. : Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Blood Adv 6(13): 3997-4005, Jul 2022.

Matthews AH, Yui J, Chiang EY, Pishko AM, Cuker A, Cucchiara BL, George D, Sayani F, Mullen MT.: Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Potential Cause of Cryptogenic Stroke. J Stroke Cerebrovasc Dis. J Stroke Cerebrovasc Dis 31(6): 106431, Jun 2022.

Berwick S, Hila C, Matthews AH, Mukhopadhyay A, Poole B, Talan J, Hayes M, Smith C.: “Frequency and Impact of Gender-Biased Professional Misidentification of Resident Physicians.” Academic Medicine. Acad Med 96(6): 869-875, Jun 2021.

Halaby R, Cuker A, Yui J, Matthews AH, Ishaaya E, Traxler E, Domenico C, Cooper T, Tierney A, Niami P, van der Rijst N, Adusumalli S, Gutsche J, Giri J, Pugliese S, Hecht TEH, Pishko AM. : Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study. J Thromb Haemost 19(6): 1533-1545, Jun 2021.

Matthews AH, Hall, M., Parra, J. M., Hayes, M. M., Beltran, C. P., Ranchoff, B. L., Sullivan, A. M., & William, J. H. : Receiving Real-Time Clinical Feedback: A Workshop and OSTE Assessment for Medical Students. Advances in Medical Education and Practice. Adv Med Educ Pract 11: 861-867, Nov 2020.

Jain S, Van Scoyk A, Morgan EA, Matthews AH, Stevenson K, Newton G, Powers F, Autio A, Louissaint A, Pontini G, Aster J, Luscinskas F, Weinstock DM.: Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas. Blood 134(17): 1430-1440, Oct 2019.